A&A Ayrshire and Arran Health Board
ADE Adverse drug event
ADR Adverse drug reaction
BAP British Association for Psychopharmacology
B-Z Benzodiazepines and/or z-hypnotics
CBT Cognitive behavioural therapy
cCBT Computerised Cognitive Behavioural Therapy
COPD Chronic Obstructive Pukmonary Disease
DDD Average defined daily
D&G Dumfries and Galloway Health Board
DMARDs Disease-modifying antirheumatic drugs
DOAC Direct oral anticoagulant
ECT Electro Convulsive Treatment
eGFR estimated glomerular filtration rate
EScro Enhanced Services Contracting Reporting Options
FV Forth Valley Health Board
GAD Generalized anxiety disorder
GGC Greater Glasgow and Clyde Health Board
HSCP Health and Social Care Partnership
ISD Information Service Division
LVSD Left ventricular systolic dysfunction
MAOI Monoamine oxidase inhibitor
MHRA Medicines and Health Care Products Regulatory Agency
MR Modified Release
NICE National Institute for Clinical Excellence
NNT Numbers Needed to Treat
NSAID Non-steroidal anti-inflammatory drug
OCD Obsessive compulsive disorder
PHQ-9 Patient Health Questionnaire
PTSD Post-traumatic stress disorder
QOF Quality and Outcomes Framework
SNRI Serotonin and noradrenaline re-uptake inhibitor
SSRI Selective serotonin re-uptake inhibitor
STU Scottish Therapeutics Utility
TCA Tricyclic antidepressants
WI Western Isles Health Board


Expand this content